id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-2297-0005,FDA,FDA-2020-N-2297,Microbiology Devices; Reclassification of Human Immunodeficiency Virus Viral Load Monitoring Tests,Rule,Final Rule,2022-11-04T04:00:00Z,2022,11,2022-11-04T04:00:00Z,,2022-11-04T14:30:17Z,2022-23868,0,0,0900006485488260
FDA-2020-N-2297-0001,FDA,FDA-2020-N-2297,Microbiology Devices; Reclassification of Human Immunodeficiency Virus Viral Load Monitoring Tests,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2021-11-24T05:00:00Z,2021,11,2021-11-24T05:00:00Z,2022-01-25T04:59:59Z,2022-11-04T14:31:08Z,2021-25372,0,0,0900006484e7c9c0